Atlas Trials

Magnetic Resonance Imaging in Immune Effector Cell-Associated Neurotoxicity Syndrome

Clinical trial NCT05510596 · COMPLETED

Trial details

NCT number
NCT05510596
Sponsor
University Hospital, Montpellier
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Lymphoma, B-CellNeurotoxicity
Start date
2022-09-22
Primary completion
2023-09-13
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.